Year archive

Hutchmed (China) Limited — 2017 filings

All 88 regulatory filings released by Hutchmed (China) Limited (HCM) in 2017, sourced directly from the official regulator.

88 Filings

2017 Period

2017 filings (88)

Filing	Released	Lang
6-K Regulatory Filings	2017-12-29	English
6-K Regulatory Filings	2017-12-15	English
SC 13D Major Shareholding Notification	2017-11-09	English
6-K Regulatory Filings	2017-11-01	English
6-K Regulatory Filings	2017-10-31	English
6-K Regulatory Filings	2017-10-27	English
6-K Regulatory Filings	2017-10-26	English
424B5 Regulatory Filings	2017-10-26	English
6-K Regulatory Filings	2017-10-25	English
424B5 Regulatory Filings	2017-10-24	English
6-K Regulatory Filings	2017-10-19	English
6-K Regulatory Filings	2017-10-17	English
6-K Regulatory Filings	2017-10-16	English
6-K Regulatory Filings	2017-10-12	English
6-K Regulatory Filings	2017-09-29	English
6-K Regulatory Filings	2017-08-31	English
6-K Regulatory Filings	2017-08-29	English
6-K Regulatory Filings	2017-08-22	English
6-K Regulatory Filings	2017-08-18	English
6-K Regulatory Filings	2017-08-15	English
6-K Regulatory Filings	2017-08-10	English
6-K Regulatory Filings	2017-08-07	English
6-K Regulatory Filings	2017-07-31	English
6-K Regulatory Filings	2017-06-30	English
Total Voting Rights Regulatory Filings	2017-06-30	English
6-K Regulatory Filings	2017-06-29	English
Blocklisting Six Monthly Return Regulatory Filings	2017-06-29	English
Start of Savolitinib Global PRCC Phase III Trial Regulatory Filings	2017-06-29	English
Chi-Med to Announce 2017 HY Financial Results Report Publication Announcement	2017-06-29	English
6-K Regulatory Filings	2017-06-22	English
Chi-Med starts Ph I/II Trial of HMPL 453 in China Regulatory Filings	2017-06-22	English
6-K Regulatory Filings	2017-06-16	English
Director's Share Dealing Director's Dealing	2017-06-16	English
6-K Regulatory Filings	2017-06-12	English
Fruquintinib NDA for Advanced CRC Filed with CFDA Regulatory Filings	2017-06-12	English
6-K Regulatory Filings	2017-06-06	English
Phase III Fruquintinib Data presented at ASCO Regulatory Filings	2017-06-06	English
6-K Regulatory Filings	2017-05-18	English
Chi-Med Presents Clinical Data at ASCO 2017 Regulatory Filings	2017-05-18	English
Regulatory Filings 2017 Regulatory Filings	2017-05-12	English
Total Voting Rights Regulatory Filings	2017-04-28	English
6-K Regulatory Filings	2017-04-28	English
6-K Regulatory Filings	2017-04-27	English
Results of Annual General Meeting Declaration of Voting Results & Voting Rights Announcements	2017-04-27	English
6-K Regulatory Filings	2017-04-07	English
Pre-clinical Data Presented at AACR Regulatory Filings	2017-04-07	English
F-3ASR Regulatory Filings	2017-04-03	English
6-K Regulatory Filings	2017-03-31	English
Total Voting Rights Regulatory Filings	2017-03-31	English
6-K Regulatory Filings	2017-03-29	English
Vesting of LTIP awards Director's Dealing	2017-03-29	English
6-K Regulatory Filings	2017-03-28	English
Grant of Share Options under Share Option Scheme Share Issue/Capital Change	2017-03-28	English
6-K Regulatory Filings	2017-03-27	English
2016 Annual Report and Notice of AGM Report Publication Announcement	2017-03-27	English
6-K Regulatory Filings	2017-03-24	English
Appointment of Director Board/Management Information	2017-03-24	English
6-K Regulatory Filings	2017-03-21	English
Chi-Med to host R&D Briefings Regulatory Filings	2017-03-21	English
6-K Regulatory Filings	2017-03-20	English
Directors' Share Dealing Director's Dealing	2017-03-20	English
6-K Regulatory Filings	2017-03-16	English
Grant of Awards under Long Term Incentive Plan Regulatory Filings	2017-03-16	English
20-F Annual Report FY 2016	2017-03-13	English
6-K Regulatory Filings	2017-03-13	English
Publication of Form 20-F Report Publication Announcement	2017-03-13	English
Final Results Earnings Release FY 2016	2017-03-13	English
6-K Regulatory Filings	2017-03-10	English
Sulfatinib Phase Ib/II Results Presented at ENETS Regulatory Filings	2017-03-10	English
Sulfatinib Phase Ib/II Results Presented at ENETS Regulatory Filings	2017-03-10	English
EQS-News: Edison issues update on Hutchison China Meditech (HCM) Regulatory Filings	2017-03-07	English
6-K Regulatory Filings	2017-03-03	English
Positive Fruquintinib Pivotal Phase III Results Regulatory Filings	2017-03-03	English
6-K Regulatory Filings	2017-02-28	English
Change of Directors Board/Management Information	2017-02-28	English
6-K Regulatory Filings	2017-02-21	English
Start of Phase II Savolitinib PSC trial in China Regulatory Filings	2017-02-20	English
6-K Regulatory Filings	2017-02-14	English
Initiates Phase I of Novel FGFR Inhibitor HMPL-453 Regulatory Filings	2017-02-14	English
Savolitinib PRCC Results Presentation at ASCO GU Regulatory Filings	2017-02-14	English
SCHEDULE 13G Major Shareholding Notification	2017-02-13	English
SC 13G Major Shareholding Notification	2017-02-08	English
Regulatory Filings 2017 Regulatory Filings	2017-02-06	English
Chi-Med to Announce 2016 Final Results Report Publication Announcement	2017-02-06	English
6-K Regulatory Filings	2017-02-01	English
6-K Regulatory Filings	2017-01-17	English
6-K Regulatory Filings	2017-01-10	English
6-K Regulatory Filings	2017-01-10	English

Filings by year

2026 30 filings
2025 104 filings
2024 105 filings
2023 108 filings
2022 96 filings
2021 149 filings
2020 122 filings
2019 71 filings
2018 77 filings
2017 88 filings
2016 81 filings
2015 53 filings
2014 28 filings
2013 23 filings